These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 24060096

  • 21. The diagnostic value of fetal fibronectin testing in clinical practice.
    Cornelissen LGH, van Oostrum NHM, van der Woude DAA, Rolf C, Porath MM, Oei SG, van Laar JOEH.
    J Obstet Gynaecol Res; 2020 Mar; 46(3):405-412. PubMed ID: 31955485
    [Abstract] [Full Text] [Related]

  • 22. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study.
    Levine LD, Downes KL, Romero JA, Pappas H, Elovitz MA.
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [Abstract] [Full Text] [Related]

  • 23. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
    Ruma MS, Betts M, Dodman S, Neupane B.
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
    [Abstract] [Full Text] [Related]

  • 24. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM, Liu E, Allenby K.
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [Abstract] [Full Text] [Related]

  • 25. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F, Fortin S, Delvin E, Djemli A, Brunet S, Dubé J, Fraser WD.
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of quantitative fFn test in predicting the risk of preterm birth.
    Centra M, Coata G, Picchiassi E, Alfonsi L, Meniconi S, Bini V, Di Tommaso MR, Cozzolino M, Facchinetti F, Ferrari F, Gervasi MT, Rusconi S, Todros T, Frisina V, Rizzo N, Bisulli M, Di Renzo GC.
    J Perinat Med; 2017 Jan 01; 45(1):91-98. PubMed ID: 27049613
    [Abstract] [Full Text] [Related]

  • 27. Quantitative fetal fibronectin predicts preterm birth in women with bulging fetal membranes.
    Fiorini F, Isted A, Hezelgrave NL, Shennan AH.
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug 01; 203():127-31. PubMed ID: 27280542
    [Abstract] [Full Text] [Related]

  • 28. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM, Sener T, Yildiz Z.
    Clin Exp Obstet Gynecol; 2008 Aug 01; 35(1):61-4. PubMed ID: 18390084
    [Abstract] [Full Text] [Related]

  • 29. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK, Jones J, Rose M, Payne L.
    Health Technol Assess; 2016 Nov 01; 20(87):1-160. PubMed ID: 27918253
    [Abstract] [Full Text] [Related]

  • 30. Accuracy of fetal fibronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study.
    Fuchs F, Lefevre C, Senat MV, Fernandez H.
    Sci Rep; 2018 Feb 01; 8(1):2160. PubMed ID: 29391455
    [Abstract] [Full Text] [Related]

  • 31. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H, Gallacher D, Achana F, Court R, Taylor-Phillips S, Nduka C, Stinton C, Willans R, Gill P, Mistry H.
    Health Technol Assess; 2020 Jun 01; 24(31):1-232. PubMed ID: 32605705
    [Abstract] [Full Text] [Related]

  • 32. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, Price MJ, Bates EJ, Turner AM, Bayliss S, Moore D, Singh S, Adab P, Fitzmaurice DA, Jowett S, Jolly K.
    Health Technol Assess; 2015 May 01; 19(36):1-516. PubMed ID: 25980984
    [Abstract] [Full Text] [Related]

  • 33.
    Desser AS, Arentz-Hansen H, Fagerlund BF, Harboe I, Lauvrak V.
    ; 2017 08 25. PubMed ID: 29553663
    [Abstract] [Full Text] [Related]

  • 34. Evaluating the use of the QUiPP app and its impact on the management of threatened preterm labour: A cluster randomised trial.
    Watson HA, Carlisle N, Seed PT, Carter J, Kuhrt K, Tribe RM, Shennan AH.
    PLoS Med; 2021 Jul 25; 18(7):e1003689. PubMed ID: 34228735
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of quantitative fetal fibronectin in predicting spontaneous preterm birth in symptomatic women: A retrospective cohort study.
    Nguyen AD, Liu CZ, Lehner C, Amoako AA, Sekar R.
    Aust N Z J Obstet Gynaecol; 2019 Oct 25; 59(5):656-661. PubMed ID: 30724331
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers HC, Spaanderman ME, Bloemenkamp KW, Haak MC, Bolte AC, Vandenbussche FP, Woiski MD, Bax CJ, Cornette JM, Duvekot JJ, Nij Bijvank BW, van Eyck J, Franssen MT, Sollie KM, van der Post JA, Bossuyt PM, Opmeer BC, Kok M, Mol BW, van Baaren GJ.
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov 25; 206():220-224. PubMed ID: 27750180
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
    van Baaren GJ, Vis JY, Grobman WA, Bossuyt PM, Opmeer BC, Mol BW.
    Am J Obstet Gynecol; 2013 Nov 25; 209(5):436.e1-8. PubMed ID: 23791688
    [Abstract] [Full Text] [Related]

  • 38. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I, Wallwiener D, Schmidt S.
    J Perinat Med; 2005 Nov 25; 33(5):383-91. PubMed ID: 16238532
    [Abstract] [Full Text] [Related]

  • 39. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ, Manyame S, Medley N, Williams MJ.
    Cochrane Database Syst Rev; 2019 Sep 16; 9(9):CD011192. PubMed ID: 31523806
    [Abstract] [Full Text] [Related]

  • 40. Fetal fibronectin test for threatened preterm delivery 48h after admission: Cost-effectiveness study.
    Mourgues C, Rossi A, Favre N, Delabaere A, Roszyk L, Sapin V, Debost-Legrand A, Gallot D.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar 16; 234():75-78. PubMed ID: 30660942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.